|
⚲
|
| Keyboard |
| Arnold Susan Elizabeth
✚
|
|
|---|---|
| CIK # | 0001755746 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001755746] | |
| 4 | [0001755746] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| PhaseBio Pharmaceuticals Inc | |
| Arnold Susan Elizabeth |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-20 | Grant | 10,917 | $0.68 | 7,424 |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Unit · derivative
|
2022-02-24 | Grant | 18,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2022-02-24 | Grant | 87,500 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-11-19 | Grant | 2,559 | $2.01 | 5,144 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-07-12 | Grant | 4,519 | $1.74 | 7,863 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-05-20 | Grant | 5,257 | $2.80 | 14,720 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2021-02-05 | Grant | 36,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2020-11-20 | Grant | 4,832 | $3.00 | 14,496 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-10-01 | Option exercise | 5,423 | $1.15 | 6,236 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2020-10-01 | Option exercise | 5,423 | $1.15 | 6,236 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2020-02-27 | Option exercise | 5,423 | $1.15 | 6,236 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-02-27 | Option exercise | 5,423 | $1.15 | 6,236 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 55,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2019-02-27 | Grant | 45,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 2,306 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 103 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Conversion | 2,306 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 103 | $0.12 | 12 |